[Skip to Navigation]
JAMA Cardiology Clinical Evidence Synopsis
July 2017

Efficacy of Catheter Ablation for Nonparoxysmal Atrial Fibrillation

Author Affiliations
  • 1Division of Cardiology, Department of Medicine, McMaster University, Hamilton, Ontario, Canada
  • 2Institute of Health Informatics, Faculty of Population Health Sciences, University College London, London, United Kingdom
  • 3Department of Cardiac Sciences, Cumming School of Medicine, Foothills Medical Centre, Calgary, Alberta, Canada
JAMA Cardiol. 2017;2(7):812-813. doi:10.1001/jamacardio.2017.0901
Abstract

Clinical Question  Is catheter ablation better than antiarrhythmic drugs for the prevention of nonparoxysmal atrial fibrillation?

Bottom Line  Radiofrequency catheter ablation was found to be superior to antiarrhythmic drugs in preventing recurrences of nonparoxysmal atrial fibrillation and reducing hospital admissions.

Add or change institution
×